olmesartan medoxomil has been researched along with Duodenal Diseases in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hair, C; Heerasing, N; Wallace, S | 1 |
1 other study(ies) available for olmesartan medoxomil and Duodenal Diseases
| Article | Year |
|---|---|
Olmesartan-induced enteropathy.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Dose-Response Relationship, Drug; Duodenal Diseases; Duodenoscopy; Duodenum; Female; Follow-Up Studies; Humans; Hypertension; Imidazoles; Olmesartan Medoxomil; Tetrazoles | 2015 |